Evaluation of treatments for the vaccination against hepatitis B + thymopentine.

A series of 43 patients--who were suffering from uremia, subject to hemodialysis treatment, resulting seronegative to the test for HBV and who had never been vaccinated before--considering the HBS antibody as seroconversion index are studied, obtaining a significant seroconversions in terms of patients, if compared with the other groups.